All Stories

  1. Combination Therapy in Pulmonary Fibrosis: A New Era

    Article • Archivos de Bronconeumología (English Edition), May 2026, Elsevier

    Dr Giovanni Ferrara

  2. “I just know I don’t know”: challenging the interpretation of clinical trials grounded in imperfect assumptions

    Article • American Review of Respiratory Disease, April 2026, Oxford University Press (OUP)

    Dr Giovanni Ferrara

  3. End-user global study to identify countries’ challenges and solutions in the uptake and implementation of new tuberculosis treatment regimens

    Article • European Respiratory Journal, March 2026, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  4. Targeting Vascular Inflammation In Patients with Community-Acquired Pneumonia (TIN-CAP): protocol for a multicentre, randomised, double-blind, placebo-controlled trial

    Article • BMJ Open, March 2026, BMJ

    Dr Giovanni Ferrara

  5. Interstitial lung abnormalities: to treat or not to treat? The hamlet dilemma

    Article • Frontiers in Medicine, February 2026, Frontiers

    Dr Giovanni Ferrara

  6. Exploring the temporal relationship between stigma, disease manifestations, and health outcomes in post COVID-19 condition: a longitudinal descriptive study

    Article • EClinicalMedicine, November 2025, Elsevier

    Dr Giovanni Ferrara

  7. The effect of pollutant exposure on cough in progressive pulmonary fibrosis

    Article • IJTLD OPEN, October 2025, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  8. Which trial do we need? Combination regimen for individuals exposed to multidrug-resistant Mycobacterium tuberculosis

    Article • Clinical Microbiology and Infection, October 2025, Elsevier

    Dr Giovanni Ferrara

  9. Impact of Clinical Practice Guidelines on Palliative Care and Health Outcomes in Idiopathic Pulmonary Fibrosis in a Canadian Province

    Article • Annals of the American Thoracic Society, September 2025, American Thoracic Society

    Dr Giovanni Ferrara

  10. Decoding objective cough features in progressive pulmonary fibrosis: A 6-month feasibility study

    Article • The American Journal of Medicine, August 2025, Elsevier

    Dr Giovanni Ferrara

  11. Patient and provider perceptions of the impact of COVID-19 on tuberculosis healthcare access and delivery: A qualitative study of the complexities of a pandemic within a pandemic

    Article • December 2024, Springer Science + Business Media

    Dr Giovanni Ferrara

  12. The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation

    Article • Journal of Clinical Medicine, November 2024, MDPI AG

    Dr Giovanni Ferrara

  13. Refining the definition of miliary/disseminated tuberculosis in Canada

    Article • International Journal of Infectious Diseases, November 2024, Elsevier

    Dr Giovanni Ferrara

  14. Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung Diseases

    Article • Lung, September 2024, Springer Science + Business Media

    Dr Giovanni Ferrara

  15. “A Mighty Flame Can Follow a Tiny Spark”: Is This the Case of c-Jun N-Terminal Kinase 1 Inhibitors in Idiopathic Pulmonary Fibrosis?

    Article • American Review of Respiratory Disease, August 2024, American Thoracic Society

    Dr Giovanni Ferrara

  16. Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung disease

    Article • BMJ Open Respiratory Research, August 2024, BMJ

    Dr Giovanni Ferrara

  17. Opioids for dyspnoea in interstitial lung disease: does the sequence and timing of therapy matter?

    Article • European Respiratory Journal, July 2024, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  18. Factors associated with phenotypes of dyspnea in post-COVID-19 condition: a cross-sectional study

    Article • Scientific Reports, June 2024, Springer Science + Business Media

    Rachel Lim, Dr Giovanni Ferrara

  19. The clinical impact of heart failure with preserved ejection fraction in interstitial lung diseases

    Article • The International Journal of Tuberculosis and Lung Disease, June 2024, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  20. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study

    Article • The Lancet Respiratory Medicine, May 2024, Elsevier

    Dr Giovanni Ferrara

  21. The diagnostic pathway for patients with interstitial lung disease: a mixed-methods study of patients and physicians

    Article • BMJ Open Respiratory Research, April 2024, BMJ

    Dr Giovanni Ferrara

  22. Use of 6‐minute walk distance to predict lung transplant‐free survival in fibrosing non‐IPF interstitial lung diseases

    Article • Respirology, February 2024, Wiley

    Dr Giovanni Ferrara

  23. Early Organ Metastasis in Granulomatous Mycosis Fungoides: A Systematic Review

    Article • Dermatology, January 2024, Karger Publishers

    Dr Giovanni Ferrara

  24. Macrolides and Asthma Therapy

    Article • January 2024, Springer Science + Business Media

    Dr Giovanni Ferrara

  25. Chapitre 15: Le suivi du rendement du programme de lutte antituberculeuse

    Article • Canadian Journal of Respiratory Critical Care and Sleep Medicine, November 2023, Taylor & Francis

    Dr Giovanni Ferrara

  26. Characterizing long-COVID brain fog: a retrospective cohort study

    Article • Journal of Neurology, August 2023, Springer Science + Business Media

    Dr Giovanni Ferrara

  27. Less Social Deprivation Is Associated With Better Health-Related Quality of Life in Asthma and Is Mediated by Less Anxiety and Better Sleep Quality

    Article • The Journal of Allergy and Clinical Immunology In Practice, July 2023, Elsevier

    Dr Giovanni Ferrara

  28. A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings

    Article • The International Journal of Tuberculosis and Lung Disease, May 2023, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  29. Skin disorders and interstitial lung disease: Part II—The spectrum of cutaneous diseases with lung disease association

    Article • Journal of the American Academy of Dermatology, April 2023, Elsevier

    Dr Giovanni Ferrara

  30. Skin disorders and interstitial lung disease: Part I—Screening, diagnosis, and therapeutic principles

    Article • Journal of the American Academy of Dermatology, April 2023, Elsevier

    Dr Giovanni Ferrara

  31. Fibrotic or nonfibrotic interstitial lung disease in patients with primary Sjögren syndrome

    Article • Polish Archives of Internal Medicine, February 2023, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Giovanni Ferrara

  32. No one left behind: review of precision medicine and cystic fibrosis—how the changing approach to cystic fibrosis treatment might lead to tailored therapies for all

    Article • Pharmacogenomics Research and Personalized Medicine, January 2023, AME Publishing Company

    Dr Giovanni Ferrara

  33. Reliability and validity of the post COVID-19 condition stigma questionnaire: a prospective cohort study

    Article • EClinicalMedicine, January 2023, Elsevier

    Dr Giovanni Ferrara

  34. A case series of dermatomyositis following SARS-CoV-2 vaccination

    Article • Frontiers in Medicine, November 2022, Frontiers

    Dr Giovanni Ferrara

  35. Reflecting on the relationship between residential schools and TB in Canada

    Article • The International Journal of Tuberculosis and Lung Disease, September 2022, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  36. Responding to the post-pandemic crisis: post-exposure prophylaxis for TB

    Article • The International Journal of Tuberculosis and Lung Disease, September 2022, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  37. Reference equations for oscillometry and their differences among populations: a systematic scoping review

    Article • European Respiratory Review, July 2022, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  38. Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls

    Article • Frontiers in Physiology, July 2022, Frontiers

    Dr Giovanni Ferrara

  39. Chapter 15: Monitoring tuberculosis program performance

    Article • Canadian Journal of Respiratory Critical Care and Sleep Medicine, March 2022, Taylor & Francis

    Dr Giovanni Ferrara

  40. Immunomodulatory treatment of interstitial lung disease

    Article • Therapeutic Advances in Respiratory Disease, January 2022, SAGE Publications

    Dr Giovanni Ferrara

  41. COVID‐19 hospitalization is associated with pulmonary/diffusion abnormalities but not post‐acute sequelae of COVID‐19 severity

    Article • Journal of Internal Medicine, December 2021, Wiley

    Dr Giovanni Ferrara

  42. Macrolides versus placebo for chronic asthma

    Article • Cochrane Database of Systematic Reviews, November 2021, Wiley

    Dr Giovanni Ferrara

  43. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype?

    Article • Respiratory Research, August 2021, Springer Science + Business Media

    Dr Giovanni Ferrara

  44. Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management

    Article • April 2021, Springer Science + Business Media

    Meena Kalluri, Dr Giovanni Ferrara

  45. Disseminated TB: still being missed and misunderstood

    Article • The International Journal of Tuberculosis and Lung Disease, April 2021, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  46. Six-minute walking test outweighs other predictors of mortality in idiopathic pulmonary fibrosis. A real-life study from the Swedish IPF registry

    Article • Respiratory Medicine X, November 2020, Elsevier

    Dr Giovanni Ferrara

  47. Early referral to palliative care in IPF – pitfalls and opportunities in clinical trials

    Article • July 2020, Springer Science + Business Media

    Meena Kalluri, Dr Giovanni Ferrara

  48. RA-ILD: does more detailed radiological classification add something to our knowledge of this condition?

    Article • Journal of Thoracic Disease, June 2020, AME Publishing Company

    Dr Giovanni Ferrara

  49. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden

    Article • BMC Pulmonary Medicine, November 2019, Springer Science + Business Media

    Dr Giovanni Ferrara

  50. What patients with Idiopathic Pulmonary Fibrosis and caregivers want – Filling the currents gaps with patient reported outcomes and experience measures

    Article • The American Journal of Medicine, September 2019, Elsevier

    Dr Giovanni Ferrara

  51. Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015

    Article • Respiratory Medicine, August 2019, Elsevier

    Dr Giovanni Ferrara

  52. Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma

    Article • May 2019, Springer Science + Business Media

    Dr Giovanni Ferrara

  53. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study

    Article • ERJ Open Research, April 2019, European Respiratory Society (ERS)

    Dr Giovanni Ferrara, MD Pilar Rivera Ortega

  54. An Atypical Case of Idiopathic Pulmonary Fibrosis in a Patient from Africa

    Article • Medicina, March 2019, MDPI AG

    Dr Giovanni Ferrara

  55. Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden

    Article • Pulmonary Therapy, March 2019, Springer Science + Business Media

    Dr Giovanni Ferrara

  56. Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan

    Article • The International Journal of Tuberculosis and Lung Disease, October 2018, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  57. Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries

    Article • Multidisciplinary Respiratory Medicine, May 2018, Springer Science + Business Media

    Dr Giovanni Ferrara

  58. Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions

    Article • European Respiratory Review, February 2018, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  59. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study

    Article • European Respiratory Journal, August 2017, European Respiratory Society (ERS)

    Dr Anoop M Nambiar, Dr Giovanni Ferrara, Dr Michael Perch, Satoshi Ikeda, Dr Tiago M Alfaro, MD Pilar Rivera Ortega

  60. Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma

    Article • Multidisciplinary Respiratory Medicine, July 2017, Springer Science + Business Media

    Dr Giovanni Ferrara

  61. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

    Article • The Lancet Respiratory Medicine, July 2017, Elsevier

    Dr Giovanni Ferrara

  62. Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia

    Article • BMC Pulmonary Medicine, June 2017, Springer Science + Business Media

    Dr Giovanni Ferrara

  63. Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays

    Article • International Journal of Infectious Diseases, March 2017, Elsevier

    Dr Giovanni Ferrara

  64. Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays

    Article • International Journal of Infectious Diseases, March 2017, Elsevier

    Dr Giovanni Ferrara

  65. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group

    Article • Journal of Internal Medicine, November 2016, Wiley

    Dr Giovanni Ferrara

  66. Need for combined interventions and operational research to tackle tuberculous meningitis

    Article • The International Journal of Tuberculosis and Lung Disease, November 2016, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  67. Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry

    Article • European Clinical Respiratory Journal, January 2016, Taylor & Francis

    Dr Giovanni Ferrara, Andreas Palm

  68. T-Cell Therapy: Options for Infectious Diseases: Table 1.

    Article • Clinical Infectious Diseases, September 2015, Oxford University Press (OUP)

    Dr Giovanni Ferrara

  69. Macrolides for chronic asthma

    Article • Cochrane Database of Systematic Reviews, September 2015, Wiley

    Dr Giovanni Ferrara

  70. Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome

    Article • BMJ Case Reports, September 2015, BMJ

    Dr Giovanni Ferrara

  71. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis

    Article • BMC Immunology, July 2015, Springer Science + Business Media

    Dr Giovanni Ferrara

  72. Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses?

    Article • The International Journal of Tuberculosis and Lung Disease, March 2015, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  73. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review

    Article • Internal and Emergency Medicine, February 2015, Springer Science + Business Media

    Dr Giovanni Ferrara

  74. No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses

    Article • Virology, November 2014, Elsevier

    Dr Giovanni Ferrara

  75. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial

    Article • The Lancet Respiratory Medicine, February 2014, Elsevier

    Dr Giovanni Ferrara

  76. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children

    Article • Cochrane Database of Systematic Reviews, December 2013, Wiley

    Dr Giovanni Ferrara

  77. Chronic empyema: importance of preventing complications in the management of pleural effusions

    Article • BMJ Case Reports, August 2013, BMJ

    Dr Giovanni Ferrara

  78. Isoniazid preventive treatment: predictors of adverse events and treatment completion

    Article • July 2013, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  79. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence: Table 1–

    Article • European Respiratory Journal, June 2013, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  80. Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension

    Article • BMJ Case Reports, February 2013, BMJ

    Dr Giovanni Ferrara

  81. Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections

    Article • The American Journal of Medicine, October 2012, Elsevier

    Dr Giovanni Ferrara

  82. Risk factors associated with pulmonary tuberculosis

    Article • Current Opinion in Pulmonary Medicine, May 2012, Wolters Kluwer Health

    Dr Giovanni Ferrara

  83. Trends and challenges in tuberculosis in a medium-sized southern European setting [Notes from the field]

    Article • May 2012, International Union Against Tuberculosis and Lung Disease

    Dr Giovanni Ferrara

  84. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

    Article • European Respiratory Journal, April 2012, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  85. "Interferon-  release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis." R. Diel, D. Goletti, G. Ferrara, G. Bothamley, D. Cirillo, B. Kampmann, C. Lange, M. Losi, R. Markova, G.B. Migliori,...

    Article • European Respiratory Journal, February 2012, European Respiratory Society (ERS)

    Dirk Wagner, Dr Giovanni Ferrara

  86. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children

    Article • Cochrane Database of Systematic Reviews, December 2011, Wiley

    Dr Giovanni Ferrara

  87. Tuberculosis in prisons: anatomy of global neglect

    Article • European Respiratory Journal, September 2011, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  88. Screening of immigrants in the UK for latent tuberculosis

    Article • Expert Review of Respiratory Medicine, August 2011, Taylor & Francis

    Dr Giovanni Ferrara

  89. Xpert MTB/RIF test for tuberculosis

    Article • August 2011, Elsevier

    Dr Giovanni Ferrara

  90. A Decade of Interferon-γ Release Assays: Quest for the Holy Grail to Diagnose Latent Infection withMycobacterium tuberculosis?

    Article • American Review of Respiratory Disease, June 2011, American Thoracic Society

    Dr Giovanni Ferrara

  91. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis

    Article • Tuberculosis, May 2011, Elsevier

    Professor Tamara Tuuminen, Dr Giovanni Ferrara

  92. The best on infections: update from the 2010 ERS Congress

    Article • European Respiratory Journal, March 2011, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  93. Tuberculosis in prisons in sub-Saharan Africa – the need for improved health services, surveillance and control

    Article • Tuberculosis, March 2011, Elsevier

    Dr Giovanni Ferrara

  94. Interferon-  release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

    Article • European Respiratory Journal, October 2010, European Respiratory Society (ERS)

    Dr Giovanni Ferrara, Dirk Wagner

  95. TB or not TB: update from the ERS Respiratory Infection Assembly 10

    Article • European Respiratory Journal, June 2010, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  96. Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection

    Article • Archivum Immunologiae et Therapiae Experimentalis, October 2009, Springer Science + Business Media

    Dr Giovanni Ferrara

  97. Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients

    Article • July 2009, Elsevier

    Dr Giovanni Ferrara

  98. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET

    Article • European Respiratory Journal, April 2009, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  99. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

    Article • European Respiratory Journal, March 2009, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  100. Mycobacterium tuberculosis Induces CCL18 Expression in Human Macrophages

    Article • October 2008, Wiley

    Dr Giovanni Ferrara

  101. Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

    Article • European Respiratory Journal, April 2008, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev, Dr Giovanni Ferrara

  102. Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TBassay

    Article • Expert Review of Respiratory Medicine, April 2008, Taylor & Francis

    Dr Giovanni Ferrara

  103. Extensively Drug-Resistant Tuberculosis Is Worse than Multidrug-Resistant Tuberculosis: Different Methodology and Settings, Same Results

    Article • Clinical Infectious Diseases, March 2008, Oxford University Press (OUP)

    Dr Giovanni Ferrara

  104. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases

    Article • European Respiratory Journal, March 2008, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev, Dr Giovanni Ferrara

  105. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children

    Article • January 2008, Wiley

    Dr Christopher J Cates, Dr Giovanni Ferrara

  106. Clinical and operational value of the extensively drug-resistant tuberculosis definition

    Article • European Respiratory Journal, October 2007, European Respiratory Society (ERS)

    Dr Giovanni Ferrara

  107. Combination fluticasone and salmeterol vesus fixed dose combination budesonide and formoterol for chronic asthma in adults and children

    Article • July 2007, Wiley

    Dr Giovanni Ferrara

  108. Extensively Drug-resistant Tuberculosis, Italy and Germany

    Article • Emerging Infectious Diseases, May 2007, Centers for Disease Control and Prevention (CDC)

    Dr Giovanni Ferrara

  109. Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs

    Article • Respiratory Medicine, September 2006, Elsevier

    Dr Giovanni Ferrara

  110. Blood tests for diagnosis of tuberculosis – Authors' reply

    Article • The Lancet, July 2006, Elsevier

    Dr Giovanni Ferrara

  111. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

    Article • April 2006, Elsevier

    Dr Giovanni Ferrara

  112. Macrolides for chronic asthma

    Article • Cochrane Database of Systematic Reviews, October 2005, Wiley

    Dr Giovanni Ferrara

  113. Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection

    Article • American Review of Respiratory Disease, September 2005, American Thoracic Society

    Dr Giovanni Ferrara

  114. Macrolides for chronic asthma

    Article • July 2005, Wiley

    Dr Giovanni Ferrara

  115. Community Acquired Pneumonia in Internal Medicine: A One-Year Retrospective Study Based on Pneumonia Severity Index

    Article • International Journal of Immunopathology and Pharmacology, July 2005, SAGE Publications

    Dr Giovanni Ferrara

  116. Macrolides in the treatment of asthma and cystic fibrosis

    Article • Respiratory Medicine, January 2005, Elsevier

    Dr Giovanni Ferrara

  117. Corticosteroids for idiopathic pulmonary fibrosis

    Article • Cochrane Database of Systematic Reviews, July 2003, Wiley

    Dr Giovanni Ferrara

  118. Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000

    Article • European Respiratory Journal, January 2003, European Respiratory Society (ERS)

    Dr Enrico Tortoli, Dr Giovanni Ferrara

  119. Macrolides for chronic asthma

    Article • Cochrane Database of Systematic Reviews, October 2001, Wiley

    Dr Giovanni Ferrara